Last updated on February 2018

A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders


Brief description of study

This study is a phase II of effcicacy and tolerance of azacitidine in patients with myelodysplatic syndrome and steroid dependent or resistent systemic auto-immune and inflammatory disorders

Detailed Study Description

This trial will be a prospective French nationwide study analyzing the effect of treatment with azacitidine in patients with MDS-associated SAID with steroid dependence and/or resistance, and its correlation with possible changes in immunological parameters

Clinical Study Identifier: NCT02985190

Contact Investigators or Research Sites near you

Start Over

Célia SALANOUBAT, MD

CHSF Gilles de Corbeil
Corbeil-Essonnes, France
  Connect »